#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pseudomyxoma peritonei Craniopharyngioma B-cell lymphoma refractory Transferrin decreased Familial haemophagocytic lymphohistiocytosis Adult T-cell lymphoma/leukaemia refractory Thalassaemia alpha Ovarian cancer stage IV Iron overload Congenital ectodermal dysplasia Dilated cardiomyopathy Uveitis Cutaneous T-cell lymphoma recurrent Von Hippel-Lindau disease Vascular malformation More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Basic Information Chondrosarcoma metastatic – Diagnostics Lymphangioma – Diagnostics Hypereosinophilic syndrome Haemolytic uraemic syndrome – Diagnostics Prader-Willi syndrome – Diagnostics Bronchopulmonary dysplasia – Treatment Gastrointestinal stromal tumour – Trials in Disease Sarcoma – Diagnostics Mucopolysaccharidosis III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talazoparib Nadunolimab VALACICLOVIR HYDROCHLORIDE Nimotuzumab Niraparib Prednisone Betamethasone Sodium Phosphate NIZUBAGLUSTAT Oxybuprocaine Tominersen Opelconazole Quercetin Mepivacaine Hydrochloride ARTICAINE HYDROCHLORIDE Elotuzumab Pitolisant Leuprorelin Acetate Prax-628 Dobutamine Hydrochloride Gadobutrol More therapies…

    Learn about Your Condition

    Aneurysm ruptured Dent's disease Liposarcoma Mast cell activation syndrome IgA nephropathy Astrocytoma malignant Cold urticaria Anal squamous cell carcinoma Axial spondyloarthritis Cerebral palsy Post-traumatic stress disorder Muscle strain Procedural anxiety Acute leukaemia Stress urinary incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Procedural pain

  • A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    Belgium Czechia Denmark Finland France Germany +4

  • Study on the Effect of Esketamine and Sodium Chloride on Post-Craniotomy Headache in Patients with Drug-Resistant Temporal Lobe Epilepsy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Craniotomy
    • Procedural pain
    Investigated Drugs:
    • Esketamine
    • Sodium Chloride
    The Netherlands

  • Study on Preventing Chronic Pain After Hernia and Knee Surgery Using Tapentadol for Patients Undergoing These Surgeries

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Tapentadol Hydrochloride
    The Netherlands

  • Study on Pain Relief After Obesity Surgery Using Esketamine, Dexmedetomidine, and Lidocaine Hydrochloride Monohydrate for Patients Undergoing Obesity Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    • Obesity
    Investigated Drugs:
    • Remifentanil Hydrochloride
    • Dexmedetomidine
    • Esketamine
    Sweden

  • Study on Preventing Persistent Postoperative Pain in Children Using Mepivacaine Hydrochloride and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Nalbuphine Hydrochloride
    • Ondansetron Hydrochloride
    • Sevoflurane
    France

  • Study on Sufentanil’s Effect on Chronic Pain After Non-Major Abdominal Surgery for Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sufentanil
    France
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!